BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 9853546)

  • 1. Calcium and phosphorus in milk of Brazilian mothers using oral contraceptives.
    Dorea JG; Myazaki E
    J Am Coll Nutr; 1998 Dec; 17(6):642-6. PubMed ID: 9853546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of oral contraceptive use on iron and copper concentrations in breast milk.
    Dorea JG; Miazaki ES
    Fertil Steril; 1999 Aug; 72(2):297-301. PubMed ID: 10438999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration of fat, protein, lactose and energy in milk of mothers using hormonal contraceptives.
    Costa TH; Dorea JG
    Ann Trop Paediatr; 1992; 12(2):203-9. PubMed ID: 1381897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
    Godsland IF; Crook D; Devenport M; Wynn V
    Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility regulation in nursing women: V. Long-term influence of a low-dose combined oral contraceptive initiated at day 90 postpartum upon lactation and infant growth.
    Peralta O; Díaz S; Juez G; Herreros C; Casado ME; Salvatierra AM; Miranda P; Durán E; Croxatto HB
    Contraception; 1983 Jan; 27(1):27-38. PubMed ID: 6404597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives do not affect magnesium in breast milk.
    Dórea JG
    Int J Gynaecol Obstet; 2000 Oct; 71(1):25-31. PubMed ID: 11044538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
    Letterie GS
    Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enlarged follicles in women using oral contraceptives.
    Broome M; Clayton J; Fotherby K
    Contraception; 1995 Jul; 52(1):13-6. PubMed ID: 8521709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
    Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
    Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of oral steroidal contraceptives on magnesium concentration in breast milk.
    Urzica D; Gales C; Zamfir C; Nechifor M
    Magnes Res; 2013; 26(4):188-91. PubMed ID: 24491602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives.
    Maclennan AH
    Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of three oral contraceptives: comparison of bleeding patterns by contraceptive types and steroid levels.
    Saleh WA; Burkman RT; Zacur HA; Kimball AW; Kwiterovich P; Bell WK
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 1):1740-5; discussion 1745-7. PubMed ID: 8317516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal treatment for bleeding irregularities in Norplant implant users.
    Alvarez-Sanchez F; Brache V; Thevenin F; Cochon L; Faundes A
    Am J Obstet Gynecol; 1996 Mar; 174(3):919-22. PubMed ID: 8633669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oral contraceptives on composition and volume of breast milk.
    Lönnerdal B; Forsum E; Hambraeus L
    Am J Clin Nutr; 1980 Apr; 33(4):816-24. PubMed ID: 7361700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
    Shaaban MM; Elwan SI; el-Kabsh MY; Farghaly SA; Thabet N
    Contraception; 1984 Nov; 30(5):421-30. PubMed ID: 6440738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.